Chondroid syringoma: Diagnostic challenge with benign mixed tumour of salivary gland—A case report Authors: Vinod Mony, Ramadas Madhavan Nirmal, Ramani Lenin Parvathy Published: 2025 ABSTRACT Chondroid syringoma (CS) is a rare benign skin adnexal tumour that may be confused with various skin lesions. This tumour is thought to originate from both secretory and ductal segments of the sweat glands, and both eccrine and apocrine variants have been described. Its occurrence in other parts of body is very rare except in head and neck. This article presents the case of a 40-year-old female patient with a swelling on the dorsum of nose, diagnosed as CS. INTRODUCTION Appendageal tumours are neoplasms whose differentiation is toward one or more of the adnexal structures of the skin. Depending on their presumed origin, adnexal tumours are categorized into those with apocrine and eccrine, follicular and sebaceous differentiation. Chondroid syringoma (CS) is a rare benign skin adnexal tumour affecting commonly the head and neck region[1] and its occurrence in other parts of body is very rare.[2] As per WHO histological classification of benign appendageal tumours, CS comes under the category of tumours with apocrine and eccrine differentiation. It is a variant of syringoma usually composed of sweat gland epithelium with in a densely sclerotic stroma and often resemble adenoma of salivary gland origin, especially pleomorphic adenoma, which led to tagging chondroid syringoma as ‘mixed tumour of skin’.[3] CS is a rare subcutaneous tumour that may be confused with various skin lesions. This tumour is thought to originate from both secretory and ductal segments of the sweat glands, and both eccrine and apocrine variants have been described. CS usually affects middle aged or older age male patients. Clinically CS presents typically as a slow growing, painless, firm, subcutaneous, or intra-cutaneous nodule. The lesion usually measures between 0.5 to 3 cm in diameter. Cheek, nose and lips are the common site in head and neck region but, this tumour can also develop on the scalp, eyelid, orbit, auditory canal, hand, foot, forehead, axillary region, abdomen, penis, vulva, and scrotum. CS lesions usually are not clinically distinctive and the diagnosis is made only on microscopic examination.[4] CASE REPORT A 40-year-old female patient came to the department came to department of Oral and Maxillofacial Pathology, Rajah Muthiah Dental College and Hospital, Annamalai University with a chief complaint of a painless swelling on the nose. The swelling had evolved over a period of 2 years. Initially the swelling was small and reached to the present-day size. Extraoral examination revealed a diffuse swelling on the dorsum of the nose of about 3 × 2 cm in size with the presence of a punctum. No evidence of pus or sebum discharge were found. Facial asymmetry with mild obliteration of the nasolabial fold was present [Figure 1]. Clinical picture showing diffuse swelling on the dorsum of the nose with the presence of a punctum Considering all these features a provisional diagnosis of sebaceous cyst on the dorsum of the nose was made. Differential diagnosis includes mixed tumours of salivary gland, glomus tumour and other benign adnexal tumours such as syringoma and hidradenoma. After getting an informed consent, an excision biopsy was conducted to arrive at a definite diagnosis. The patient was sent to the department of Oral surgery for biopsy and an excision biopsy was conducted under local anaesthesia. Biopsy specimen was greyish brown in colour and of about 3 × 2 cm that was rigid in consistency with irregular surface and ill-defined borders. The specimen was processed and the prepared slide was stained with Haematoxylin and Eosin. Histopathology showed epithelial components arranged in islands and cords [Figure 2] and the high-power view of the section showed small basaloid epithelial cells arranged in solid islands and cords. Few cystic spaces were seen lined with a single row of epithelial cells with pale eosinophilic material and the stroma is mostly hyalinized to myxoid [Figure 3]. Also, epithelial cells were arranged in a linear fashion with one or two rows of epithelial cells lining the tubular lumen [Figure 4]. Based on histopathology it was diagnosed as CS. To further confirm, immunohistochemical analysis was conducted using eccrine specific anti-keratin antibody 5 and 6 (EKH 5 and 6) and the parenchyma was positive. [Figure 5] Thus, histopathology and immunohistochemistry confirmed the diagnosis of CS. Haematoxylin and eosin staining showing epithelial components arranged in islands and cords (H&E, 40x) Haematoxylin and eosin staining showing cystic spaces lined with a single row of epithelial cells with pale eosionopilic material and the stroma is mostly hyalinized to myxoid (H&E, 40x) Haematoxylin and eosin staining showing epithelial cells arranged in a linear fashion with one or two rows of epithelial cells lining the tubular lumen (H&E, 40x) Immunohistochemical expression of eccrine specific anti-keratin antibody 5 and 6 DISCUSSION Adnexal tumours are neoplasms whose differentiation is toward one or more of the adnexal structures of the skin. As per WHO histological classification (2005) benign appendageal tumours are classified as tumours with apocrine and eccrine differentiation, Tumours with follicular differentiation and tumours with sebaceous differentiation. CS which was first described by Billorth in 1859[5] comes under the first category. The term CS was coined by Hirsch and Helwig and they also elaborated five specific histopathologic criteria pertaining to the lesion.[6] Considering the incidence of adnexal tumours almost 80% are seen in head and neck region. CS is rare among adnexal tumours, which accounts for less than 1% of all adnexal gland tumours and is mainly seen in the cheek and nose in the head and neck region.[78] In oral cavity almost 90% of CS are seen in lips and 80% affect older persons. Eccrine glands primarily serve in regulation of heat and apocrine glands represent scent glands. They differ in origin, distribution, size and mode of secretion. According to WHO, CS are cutaneous mixed tumours that are benign adnexal tumours of skin, composed of epithelial and stromal elements with a wide spectrum of patterns. These tumours are histologically analogous to mixed tumours of salivary glands, but lack the tendency for local recurrence seen in later lesions. Both apocrine and eccrine variants of the tumour are seen. Histopathology of CS shows a well circumscribed lesion located in dermis and/or subcutis. Biphasic growth pattern is readily detected with epithelial elements embedded in a myxoid, chondroid or fibrous stroma. Epithelium often shows a pattern of branching tubules with tubular lumina lined by either two rows or a single row of epithelial cells and the lumen may be filled with eosinophilic material. Epithelial cells are also seen arranged as solid cords and islands as well as single cells. The stroma may be fibrous, myxoid, chondroid, hyalin, osseous or adipoid. Mixed tumours may exhibit clear cell change with in the epithelial cells, about 40% of tumours contain ovoid hyaline cells with dense ground glass or hyaline-like cytoplasm having an eccentric nucleus that resembles plasma cells and these types of cells are known as plasmacytoid cells. Despite the name CS, chondroid areas may be absent in the stroma. Ultra structure study shows that myoepithelial cells surround the epithelial cells and these cells appear to produce the stromal components. Stroma contains Type II and IV collagen, tenascin, fibronectin and laminin. Considering the differential diagnosis in lesions with abundant epithelial elements, includes other benign adnexal tumours such as syringoma and hidradenoma, depending on the pattern of epithelial growth. In lesions with more chondromyxoid area differential diagnosis includes mixed tumours of salivary glands. Occasionally, glomus tumour can also mimic CS. It can be differentiated by the presence of strong positivity for smooth muscle actin (SMA) in immunohistochemical study. Special stains for this lesion include alcian blue with hyaluronidase resistance, which shows a strong positivity. It stains metachromatically with toluidine blue or Giemsa and, for mucicarmine and aldehyde fuchsin. Hyalinized areas are PAS +ve and diastase resistant.[9] Immunohistochemical studies, the parenchyma is positive for eccrine specific anti-keratin antibody 5 and 6 (EKH 5 and 6), cytokeratin, vimentin and S-100.[10] The treatment of cutaneous mixed tumours is total surgical excision. Unlike mixed tumours of salivary gland the recurrence rate is very less.[11] Malignant form of CS commonly occur in younger females and more seen in trunk and extremities.[21213] Usually, malignant tumours are greater than 3 cm in size but benign lesion measuring more than 10 cm also have been reported.[14] Treatment for malignant lesion includes surgical excision as an initial part followed by radiotherapy with or without chemotherapy.[213] In the case of recurrence a surgical re-excision is needed.[15] CONCLUSION To conclude, according to the literature and WHO. adnexal tumours have the highest incidence in head and neck region. However accurate diagnosis of adnexal tumours is often difficult for an oral pathologist because, many of these tumours resemble salivary gland tumours and due to the inadequacy of sufficient literature in oral and maxillofacial pathology text books. Therefore, we underscore the need for better understanding of such pathologies, without which our knowledge in the field of oral and maxillofacial pathology is incomplete. Declaration of patient consent The authors had obtained all necessary consent from the patient including consent for surgical excision and for using the image and other clinical information to be reported in the journal. The patient was informed that their names and initials will not be published and necessary efforts will be taken to conceal their identity, but anonymity cannot be guaranteed, Conflicts of interest There are no conflicts of interest.